Insiders who reported open-market trades in the last 12 months at the companies Aimee J. Lenar files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
PAULSON CO. INC. - $15.63M in BHC purchases and sales in the last 12 months
Frank D. Lee - $133K in BHC purchases and sales in the last 12 months
Seana Carson - $115K in BHC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Aimee J. Lenar is a corporate insider, tracked as President, US Pharma of Bausch Health Companies Inc. (BHC). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Aimee J. Lenar submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Aimee J. Lenar been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($259K) across all tracked filings.
Aimee J. Lenar is President, US Pharma of Bausch Health Companies Inc. (BHC). 6 SEC Form 4 filings on record going back to 2025, most recently on 20 August 2026. Most recent open-market trade: sold $259K of BHC on 20 August 2026. Lifetime open-market sales: $259K.
Recent transactions
7
The latest 7 SEC Form 4 transactions reported by Aimee J. Lenar.
InsiderAlpha's records for Aimee J. Lenar go back to 2025: 6 primary Form 4 filings, an average of 3.0 per year. 1 recorded transaction carries a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
